Slides from Driving Advances in Liver Health—HCV: Paving the Way to Elimination

Expert selections of important viral hepatitis data from EASL 2022, including studies of patients with HBV, HDV (hepatitis delta virus), and HCV, from Clinical Care Options (CCO)

Tarik Asselah, MD, PhD Stefan Zeuzem, MD Released: July 6, 2022

Clinical Care Options (CCO) commentary from Oluwaseun Falade-Nwulia, MBBS, MPH, on the need for integrating HCV services into addiction medicine settings

Oluwaseun Falade-Nwulia, MBBS, MPH Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: March 30, 2022 Expired: March 29, 2023

Clinical Care Options (CCO) commentary with advice for healthcare professionals from a person who has lived with and been cured of HCV infection

Shelley Rossell Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: March 24, 2022 Expired: March 23, 2023

Download key slides describing lessons learned in delivery of care from the COVID-19 pandemic worth carrying forward in the management of viral hepatitis.

Gregory Dore, MBBS, PhD, FRACP, MPH Jordan J. Feld, MD, MPH Graham R. Foster, FRCP, PhD Robert G. Gish, MD Paul Y. Kwo, MD Pietro Lampertico, MD, PhD Nancy Reau, MD Norah Terrault, MD, MPH Stacey Trooskin, MD, PhD, MPH Grace LH Wong, MD Released: March 16, 2022